Digital Breast Tomosynthesis Equipment Market, By Product Type (Equipment, Upgradation), By End User (Hospitals, Diagnostic Centres), By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportun

Digital Breast Tomosynthesis Equipment Market, By Product Type (Equipment, Upgradation), By End User (Hospitals, Diagnostic Centres), By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Digital Breast tomosynthesis is an advanced form of mammography which utilizes low-dose x-rays to diagnose breast cancer by creating three-dimensional images. Major advantage of digital breast tomosynthesis constitutes of improved visualization of breast tissue. DBT eliminates the challenge associated with screening of overlapping structures in the breast, therefore offering the potential to improve invasive cancer detection. Increasing incidence of breast cancer is a major factor boosting growth of the global digital breast tomosynthesis (DBT) equipment market over the forecast period. Furthermore,
Key features of the study:
This report provides in-depth analysis of the global Digital Breast Tomosynthesis (DBT) Equipment and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global Digital Breast Tomosynthesis (DBT) Equipment based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include Hologic, Inc., Internazionale Medico Scientifica S.r.l, GE Healthcare, Siemens Healthineers, Fujifilm Corporation, and Planmed OY.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global Digital Breast Tomosynthesis (DBT) Equipment report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Digital Breast Tomosynthesis (DBT) Equipment Market, By Product Type:
Equipment
Upgradation
Digital Breast Tomosynthesis (DBT) Equipment Market, By End User:
Hospitals
Diagnostic Centres
Digital Breast Tomosynthesis (DBT) Equipment Market, By Region:
North America
By Product Type:
Equipment
Upgradation
By End User
Hospitals
Diagnostic Centres
By Country:
U.S.
Canada
Latin America
By Product Type:
Equipment
Upgradation
By End User
Hospitals
Diagnostic Centres
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type:
Equipment
Upgradation
By End User
Hospitals
Diagnostic Centres
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
Equipment
Upgradation
By End User
Hospitals
Diagnostic Centres
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product Type:
Equipment
Upgradation
By End User
Hospitals
Diagnostic Centres
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Equipment
Upgradation
By End User
Hospitals
Diagnostic Centres
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Hologic, Inc.*
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Internazionale Medico Scientifica S.r.l
GE Healthcare
Siemens Healthineers
Fujifilm Corporation
Planmed OY
“*” marked represents similar segmentation in other categories in the respective section.